A human iPSC-Derived myelination model for investigating fetal brain injuries

Tsuyoshi Hiraiwa1,2, Shoko Yoshii2,3, Jiro Kawada4

  • 1Department of Obstetrics and Gynecology, Fukushima Medical University, Fukushima, Japan.

Regenerative Therapy
|March 31, 2025
PubMed

Insights

Researchers developed a human iPSC-derived model using microfluidics to study brain development and injury. This innovative platform recapitulates axon-glia interactions and myelination in vitro, advancing myelin biology research.

Area of Science:

  • Neuroscience
  • Developmental Biology
  • Biotechnology

Background:

  • Cerebral white matter injuries, like periventricular leukomalacia, significantly impact preterm infant neurodevelopment.
  • Current human models for studying fetal brain development and injury are limited.
  • Understanding axon-glia interactions and myelination is crucial for neurodevelopmental research.

Purpose of the Study:

  • To develop a human-relevant in vitro model for studying myelination and cerebral white matter injuries.
  • To recapitulate key aspects of fetal brain development and injury mechanisms.
  • To provide a platform for investigating pathologies and enabling drug screening.

Main Methods:

  • Utilized human induced pluripotent stem cells (iPSCs) to derive neuronal and oligodendrocyte spheroids.
  • Integrated these spheroids into a microfluidic device to mimic in vivo microenvironments.
  • Employed immunostaining, transmission electron microscopy, and functional calcium imaging for validation.

Main Results:

  • Successfully established axonal fascicle formation and compact myelin deposition in vitro.
  • Confirmed neuronal activity through functional calcium imaging, demonstrating physiological relevance.
  • Observed partial myelination efficiency, with some axons remaining unmyelinated.

Conclusions:

  • The human iPSC-derived microfluidic model represents a significant advancement in studying human myelin biology.
  • This model provides a foundation for investigating fetal and perinatal brain injuries.
  • Future refinements can enhance its utility for disease modeling and drug discovery.